Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
1995-1-13
pubmed:abstractText
Three anti-emetic treatment regimens were compared in 357 patients receiving cisplatin therapy (mean dose 81 mg/m2) in this double-blind randomized study. Regimens studied were i) granisetron 1 mg bd orally for 7 days (granisetron alone); ii) gran 1 mg bd orally for 7 days plus prophylactic dexamethasone (12 mg i.v.) on the first day only (gran/dex); iii) metoclopramide (3 mg/kg i.v. loading dose; 4 mg/kg i.v. infusion) plus dex (12 mg i.v.) on the first day followed by met 10 mg orally tds for a further 6 days (met/dex).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0923-7534
pubmed:author
pubmed:issnType
Print
pubmed:volume
5
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
579-4
pubmed:dateRevised
2004-11-17
pubmed:meshHeading
pubmed-meshheading:7993831-Administration, Oral, pubmed-meshheading:7993831-Adult, pubmed-meshheading:7993831-Aged, pubmed-meshheading:7993831-Chi-Square Distribution, pubmed-meshheading:7993831-Cisplatin, pubmed-meshheading:7993831-Constipation, pubmed-meshheading:7993831-Dexamethasone, pubmed-meshheading:7993831-Double-Blind Method, pubmed-meshheading:7993831-Drug Therapy, Combination, pubmed-meshheading:7993831-Europe, pubmed-meshheading:7993831-Female, pubmed-meshheading:7993831-Granisetron, pubmed-meshheading:7993831-Headache, pubmed-meshheading:7993831-Humans, pubmed-meshheading:7993831-Male, pubmed-meshheading:7993831-Metoclopramide, pubmed-meshheading:7993831-Middle Aged, pubmed-meshheading:7993831-Nausea, pubmed-meshheading:7993831-Prognosis, pubmed-meshheading:7993831-South Africa, pubmed-meshheading:7993831-Vomiting
pubmed:year
1994
pubmed:articleTitle
Oral granisetron alone and in combination with dexamethasone: a double-blind randomized comparison against high-dose metoclopramide plus dexamethasone in prevention of cisplatin-induced emesis. The Granisetron Study Group.
pubmed:affiliation
Centre François Baclesse, Caen, France.
pubmed:publicationType
Journal Article, Clinical Trial, Randomized Controlled Trial, Multicenter Study